Home / Health / Hyderabad's NIMS begins human trials of coronavirus vaccine Covaxin

Hyderabad's NIMS begins human trials of coronavirus vaccine Covaxin

The healthy volunteers, who were administered the first dose of the vaccine in the morning, were stable.

Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma

Premium

Health experts have expressed skepticism about the timeline and said government pressure could be behind this

IANS Hyderabad

3 min read Last Updated : Jul 20 2020 | 9:34 PM IST

As part of human trials of Covaxin, India's first indigenous Covid-19 vaccine, two volunteers were given its first dose at the Nizam's Institute of Medical Sciences (NIMS) on Monday, doctors said.

The healthy volunteers, who were administered the first dose of the vaccine in the morning, were stable. "Both are stable and we have not found any reaction or side-effects," said Dr G. Srinivas, a member of the research team conducting the clinical trials.

The volunteers will remain under the observation of a team of doctors till Tuesday. They will be sent home but their condition will be remotely monitored by the

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in